GH replacement in 1034 growth hormone deficient hypopituitary adults: Demographic and clinical characteristics, dosing and safety

Clinical Endocrinology

Volumn 50, Issue 6, 1999, Pages 703-713

  Abs, Roger ^a   Bengtsson, Bengt Åke ^b   Hernberg Ståhl, Elizabeth ^c   Monson, John P ^d   Tauber, Jean Pierre ^e   Wilton, Patrick ^c   Wüster, Christian ^f  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d Peptide Hormones   (Sweden)

^e CHU RANGUEIL   (France)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ARTICLE; DIABETES MELLITUS; DRUG SAFETY; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; OBESITY; PITUITARY DWARFISM; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DIABETES COMPLICATIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; HYPERLIPIDEMIAS; HYPOPITUITARISM; INFANT; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBESITY; PITUITARY NEOPLASMS; QUALITY OF LIFE; REGRESSION ANALYSIS;

EID: 0033023320     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00695.x     Document Type: Article

References (41)

1. Al Shoumer, K.A., Ali, K., Anyaoku, V., Niththyananthan, R, & Johnston, D.G. (1996) Overnight metabolic fuel deficiency in patients treated conventionally for hypopituitarism. Clinical Endocrinology, 45, 171-178.
2. Assmann, G. & Schulie, H. (1993) Results and conclusions of the Prospective Cardiovascular Münster (PROCAM) study. In: Lipid Metabolism Disorders and Coronary Heart Disease (ed. G. Assmann), pp. 19-68. MMV Medizin-Verlag, München.
3. Bang, P., Eriksson, U., Sara, V., Wivall, I.L. & Hall, K. (1991) Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinologica (Copenhagen), 124, 620-629.
4. Bates, A.S., van Hoff, W., Jones, P.J. & Clayton, R.N. (1996) The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism, 81, 1169-1172.
5. Bengtsson, B.-Å., Edén, S., Lonn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L. & Isaksson, O.G. (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism, 76, 309-317.
6. Beshyah, S.A., Freemantle, C., Thomas, E. & Johnston, D.G. (1995b) Comparison of measurement of body composition by total body potassium, bioimpedance analysis, and dual-energy X-ray absorptiometry in hypopituitary adults before and during growth hormone treatment. American Journal of Clinical Nutrition, 61, 1186-1194.
7. Beshyah, S.A., Freemantle, C., Thomas, E., Rutherford, O., Page, B., Murphy, M. & Johnston, D.G. (1995a) Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clinical Endocrinology, 42, 179-189.
8. Beshyah, S.A., Shahi, M., Skinner, E., Sharp, P., Foale, R. & Johnston, D.G. (1994) Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults. European Journal of Endocrinology, 130, 451-458.
9. de Boer, H., Blok, G.J. & van der Veen, E.A, (1995) Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews, 16, 63-86.
10. Bradley, K.M., Adams, C.B., Potter, C.P., Wheeler, D.W., Anslow, P.J. & Burke, C.W. (1994) An audit of elected patients with non-functioning pituitary adenoma treated by transsphenoidal surgery without irradiation. Clinical Endocrinology, 41, 655-659.
11. Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C.H. & Erfurth, E.M. (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology, 46, 75-81.
12. Burman, P., Broman, J.E., Hetta, J., Wiklund, I., Erfurth, E.M., Hagg, E. & Karlsson, F.A. (1995) Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. Journal of Clinical Endocrinology and Metabolism, 80, 3585-3590.
13. Chan, J.M., Stampfer, M.J., Giovannucci, E., Gann, P.H., Ma, J., Wilkinson, P., Hennekens, C.H. & Pollak, M. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science, 279, 563-566.
14. Cuneo, R.C., Salomon, F., Wiles, C.M., Hesp, R. & Sönksen, P.H. (1991) Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance. Journal of Applied Physiology, 70, 695-700.
15. Doward, L.C. (1995) The development of the QoL-AGHDA: a measure to assess quality of life of adults with growth hormone deficiency. Quality of Life Research, 4, 420-421.
16. Fowelin, J., Attvall, S., Lager, I. & Bengtsson, B.-Å. (1993) Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism, 42, 1443-1447.
17. Hankinson, S.E., Willett, W.C., Colditz, G.A., Hunter, D.J., Michaud, D.S., Deroo, B., Rosner, B., Speizer, F.E. & Pollak, M. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351, 1393-1396.
18. Huffman, D.M., O'Sullivan, A.J., Freund, J. & Ho, K.K. (1995) Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. Journal of Clinical Endocrinology and Metabolism, 80, 72-77.
19. Holmes, S.J., McKenna, S.P., Doward, L.C., Hunt, S.M. & Shalet, S.M. (1995) Development of a questionnaire to access the quality of life of adults with growth hormone deficiency. Endocrinology and Metabolism, 2, 63-69.
20. Janssen, Y.J.H., Frölich, M. & Roelfsema, F. (1997) A low starting dose of Genotropin in growth hormone-deficient adults. Journal of Clinical Endocrinology und Metabolism, 82, 129-135.
21. Johannsson, G., Mårin, P., Lönn, L., Ottosson, M., Stenlof, K., Björntorp, P., Sjöström, L. & Bengtsson, B.-Å. (1997) Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism and reduces diastolic blood pressure. Journal of Clinical Endocrinology and Metabolism, 82, 727-734.
22. Johannsson, G., Rosén, T., Lindstedt, G., Bosaeus, I. & Bengtsson, B.-Å. (1996) Effect of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency. Endocrinology and Metabolism, 3, 3-12.
23. Johansson, J.O., Landin, K., Tengborn, L., Rosen, T. & Bengtsson, B.-Å. (1994) High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arteriosclerosis and Thrombosis, 14, 434-437.
24. Johansson, J.O., Larson, G., Anderson, M., Elmgren, A., Hynsjo, L., Lindahl, A., Lundberg, P.A., Isaksson, O.G.P., Lindstedt, S. & Bengtsson, B.-Å. (1995) Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology, 61, 57-66.
25. Jurgensen, J.O., Pedersen, S.A., Thucsen, L., Jørgensen, J., Ingemann-Hansen, T., Skakkebaek, N.E. & Christiansen, J.S. (1989) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, i, 1221-1225.
26. Jørgensen, J.O., Vahl, N., Nyholm, B., Juul, A., Müller, J., Möller, N., Schmitz, O., Skakkebaek, N.E. & Christiansen, J.S. (1996) Substrate metabolism and insulin sensitivity following long-term growth hormone (GH) replacement therapy in GH-deficient adults. Endocrinology and Metabolism, 3, 281-286.
27. Kelly, P.A., Djiane, J., Postel Vinay, M.C. & Edery, M. (1991) The prolactin/growth hormone receptor family. Endocrine Reviews, 2, 235-251.
28. Mårdh, G., Lundin, K., Borg, G., Jonsson, B. & Lindeberg (1994) Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 European placebo-controlled trials. Endocrinology and Metabolism, 1(suppl. A), 43-49.
29. Markussis, V., Beshyah, S.A., Fisher, C., Sharp, P., Nicolaides, A.N. & Johnston, D.G. (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults, Lancet, 340, 1188-1192.
30. Medical Outcomes Trust (1995) Bulletin, 3.
31. Møller, J., Jørgensen, J.O., Laursen, T., Frystyk, J., Naeraa, R.W., Ørskov, H. & Christiansen, J.S. (1993) Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters. Clinical Endocrinology, 39, 403-408.
32. Nass, R., Huber, R.M., Klauss, V., Müller, O.A., Schopohl, J. & Strasburger, C.J. (1995) Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. Journal of Clinical Endocrinology and Metabolism, 80, 552-557.
33. Rosén, T. & Bengtsson, B.-Å. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336, 285-288.
34. Rosén, T., Wirén, L., Wilhelmsen, L., Wiklund, I. & Bengtsson, B.-Å. (1994) Decreased psychological well-being in adult patients with growth hormone deficiency. Clinical Endocrinology, 40, 111-116.
35. Salomon, F., Cuneo, R.C., Hesp, R. & Sönksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
36. The Principal Investigators of the MONICA Project (1988) Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years. World Health Statistics Quarterly, 41, 115-140.
37. Verhelst, J., Abs, R., Vandeweghe, M., Mockel, J., Legros, J.-J., Copinschi, G., Mahler, C., Velkeniers, B., Vanhaelst, L., Van Aelst, A., De Rijdt, D., Stevenaert, A. & Beckers, A. (1997) Two years of replacement therapy in adults with growth hormone deficiency. Clinical Endocrinology, 47, 485-494,
38. Weaver, J.U., Monson, J.P., Noonan, K., John, W.G., Edwards, A., Evans, K.A. & Cunningham, J. (1995) The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 80, 153-159.
39. Wirén, L., Willhelmsen, L., McKenna, S. & Hernberg-Ståhl, E. (1996) A comparison of the quality of life of growth hormone deficient adult and a random sample population in Sweden. 22nd International Symposium on Growth Hormone and Growth Factors in Endocrinology and Metabolism, October 1996, Vienna.
40. Wüster, C. (1995) Growth hormone, insulin-like growth factors and bone metabolism. Endocrinology and Metabolism, 2, 3-12.
41. Wüster, C., Slenczka, E. & Ziegler, R. (1991) Increased prevalence of osteoporosis and arteriosclerosis in patients with conventionally substituted pituitary insufficiency: is there a need for additional growth hormone substitution? Klinishe Wochenschrift, 69, 769-773.